This online course is adapted from the 1-day CT Screening Symposium featured at the 2023 World Conference on Lung Cancer, September 9, 2023. The course is focused on lung cancer screening technologies and best practices, including topics relevant to an international audience. Faculty will provide current data to highlight successes and address knowledge gaps. As a result of the symposium, the participant will be able to apply current knowledge to advance lung cancer screening relevant to their health care setting. 

Workshop Sessions:

• Session 1: Who Should Be Screened
• Session 2: Lung Cancer Risk Assessment
• Session 3: Diagnostic Strategy
• Session 4: Application of AI in Lung Screening  

Radiologists, oncologists, pulmonologists, thoracic surgeons, radiologic technologists, researchers in the field of lung cancer, healthcare administrators, healthcare policy makers, and industry representatives involved in CT imaging and lung cancer diagnostics.

Upon completion of this activity, the participants should be able to:

• Compare differences in screening implementation models
• Critique strengths and limitations of current risk prediction tools for people who have never smoked
• Formulate diagnostics approaches to screen detected lung lesions
• Determine the role of AI and other advanced technologies in lung screening

Chairs:

• Marjolein Heuvelmans, MD, University Medical Center Groningen, Netherlands
• Stephen Lam, MD, FRCPC, Integrative Oncology, BC Cancer & the University of British Columbia, Canada
• Pyng Lee, MD, Respiratory and Critical Care Medicine, National University of Singapore, Singapore
• Chi-Fu Jeffrey Yang, MD, Massachusetts General Hospital, USA 

Presenters:

• Thirugnanam Agasthian, MD, Senior Thoracic Surgeon, Mount Elizabeth Hospital, Singapore
• Haiquan Chen, MD, Professor, Thoracic Surgery, Fudan University Shanghai Cancer Center, China
• Peter Goh, MD, Vascular & Interventional Radiologist, Group Medical Director, Parkway Radiology, Singapore
• Jin Mo Goo, MD, PhD, Radiology, Seoul National University Hospital, Republic of Korea
• Michael Gould, MD, MS, Kaiser Permanente, Bernard J. Tyson School of Medicine, USA
• Chao A. Hsiung, PhD, National Health Research Institutes, Taiwan
• Rayjean Hung, PhD, Prosserman Centre for Population Health Research, Lunenfeld-Tanenbaum Research Institute, Sinai Health, Canada
• Ella Kazerooni, MD, Radiology, University of Michigan, USA
• Carla Lamb, MD, Interventional Pulmonary / Pulmonary and Critical Care, Lahey Hospital and Medical Center, USA
• Rachael Louise Murray, PhD, MSc, MS, BSc, University of Nottingham, UK
• Renelle Myers, MD, Associate Professor, Integrative Oncology, BC Cancer, Canada
• Matthijs Oudkerk, MD, PhD, Institute for Diagnostic Accuracy, University of Groningen, Netherlands
• Lecia Sequist, MD, MPH, The Landry Family Professor of Medicine, Harvard Medical School Program Director, Cancer Early Detection & Diagnostics, Mass General Cancer Center Leader, Program in Cancer Risk, Prevention and Early Detection, USA
• Hilary Robbins, PhD MHS MSPH, International Agency for Research on Cancer, France
• Pan Chyr Yang, MD, PhD, Department of Internal Medicine, National Taiwan University College of Medicine, Taiwan
• David Yankelevitz, MD, Icahn School of Medicine at Mount Sinai, The Mount Sinai Health System, USA

The information presented is that of the contributing faculty and does not necessarily represent the views of the International Association for the Study of Lung Cancer and/or any named commercial entity providing financial support. Specific therapies discussed may not be approved and/or specified for use as indicated by the faculty presenters. Therefore, before prescribing any medication, please review the complete prescribing information, including indications, contraindications, warnings, precautions, and adverse effects.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

If you need any assistance with this activity, please email: education@iaslc.org.